doi: 10.1073/pnas.0910672106. Epub 2009 Oct 27.
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing
Affiliations
- PMID:19861545
- PMCID: PMC2768590
- DOI: 10.1073/pnas.0910672106
Item in Clipboard
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing
Murim Choi et al. Proc Natl Acad Sci U S A..
Display options
Format
Display options
Format
Abstract
Protein coding genes constitute only approximately 1% of the human genome but harbor 85% of the mutations with large effects on disease-related traits. Therefore, efficient strategies for selectively sequencing complete coding regions (i.e., "whole exome") have the potential to contribute to the understanding of rare and common human diseases. Here we report a method for whole-exome sequencing coupling Roche/NimbleGen whole exome arrays to the Illumina DNA sequencing platform. We demonstrate the ability to capture approximately 95% of the targeted coding sequences with high sensitivity and specificity for detection of homozygous and heterozygous variants. We illustrate the utility of this approach by making an unanticipated genetic diagnosis of congenital chloride diarrhea in a patient referred with a suspected diagnosis of Bartter syndrome, a renal salt-wasting disease. The molecular diagnosis was based on the finding of a homozygous missense D652N mutation at a position in SLC26A3 (the known congenital chloride diarrhea locus) that is virtually completely conserved in orthologues and paralogues from invertebrates to humans, and clinical follow-up confirmed the diagnosis. To our knowledge, whole-exome (or genome) sequencing has not previously been used to make a genetic diagnosis. Five additional patients suspected to have Bartter syndrome but who did not have mutations in known genes for this disease had homozygous deleterious mutations in SLC26A3. These results demonstrate the clinical utility of whole-exome sequencing and have implications for disease gene discovery and clinical diagnosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Coverage of targeted bases, error rate, and sensitivity to detect variants in whole-exome capture data. (A) Distribution of per-base read coverage among 5 capture experiments. A small fraction of targeted bases are poorly captured across all experiments. (B) The per-base error rate in this data set is shown as a function of read position. (C) Subject GIT 264–1 was sequenced to a mean depth of 99×. The sensitivity to detect homozygous (solid line) or heterozygous (dashed line) variants as mean depth of whole-exome sequence coverage increases from 0 to 100× is shown. Sensitivity to detect heterozygous variants increases from 81% to 90% to 95% as mean coverage is increased from 20× to 30× and 40×, and plateaus at 98%. (D) Sensitivity of detection of heterozygous variants at exact per-base coverage. Sensitivity is approximately 80% at 10× coverage, and approaches 100% at or greater than 20× per-base coverage.
Kindred GIT 264. The affected subject is indicated by the arrow, and the pedigree structure demonstrates parental consanguinity. A presumably affected sister died 4 d after premature birth (gray symbol), and there were 2 other spontaneous abortions (small triangles, disease status unknown). The parents and other relatives were free from clinical syndromes like that seen in the index case. For simplification, the mother's 10 siblings and the father's 8 siblings are not depicted in the pedigree.
Homozygous missense mutation at highly conserved position in SLC26A3 in GIT 264–1. (A)Top: Reference sequence of aa 636–668 of SLC26A3 and the corresponding DNA sequences are shown.Below: Independent Illumina DNA sequence reads from GIT 264–1 are shown. Forward and reverse reads are shown in capital and lowercase letters, respectively. The results demonstrate a homozygous missense mutation, D652N. (B) Sanger sequence of codons 651–653 ofSLC26A3 in a WT subject and GIT 264–1 are shown and confirm the D652N mutation. The mutated residue is indicated by an asterisk, and the encoded amino acids are shown in single-letter code. (C) Conservation of D652 across species. The amino acid sequence of segment 648–656 of human SLC26A3 is shown and compared to the corresponding sequence of 6 (of 39) vertebrates and identified inD. melanogaster paralogue andC. elegans orthologue. Positions identical toHomo sapiens (H.s.) are highlighted in yellow. D652 is completely conserved among all species examined. M.m.,Mus musculus; O.c.,Oryctolagus cuniculus; B.t.,Bos taurus; G.g.,Gallus gallus; X.l.,Xenopus laevis; D.r.,Danio rerio; D.m.,D. melanogaster; C.e.,C. elegans. (D) The sequence of the same segment of human SLC26A3 is compared to 9 paralogues of the human SLC26A gene family (SLC26A1-A11;SLC26A10 is a pseudogene). (E) Structure of SLC26A3. The protein has 12 transmembrane domains and a C-terminal STAS domain (highlighted in blue). The D652N mutation (red circle) lies in the STAS domain.
Additional patients withSLC26A3 mutations. Sanger sequence traces of WT and 5 subjects with homozygous mutations inSLC26A3 are shown. These include two subjects with premature termination at codon 187 (A andB); a frameshift at codon 454 resulting from a single base deletion that leads to termination at codon 458 (C); a second patient with the D652N mutation (D); and a patient with a Y520C mutation (E). (F) Conservation of Y520 across species: Y520 is conserved among all orthologues and paralogues examined.
Similar articles
- Mimicry and well known genetic friends: molecular diagnosis in an Iranian cohort of suspected Bartter syndrome and proposition of an algorithm for clinical differential diagnosis.Najafi M, Kordi-Tamandani DM, Behjati F, Sadeghi-Bojd S, Bakey Z, Karimiani EG, Schüle I, Azarfar A, Schmidts M.Najafi M, et al.Orphanet J Rare Dis. 2019 Feb 13;14(1):41. doi: 10.1186/s13023-018-0981-5.Orphanet J Rare Dis. 2019.PMID:30760291Free PMC article.
- Comprehensive comparison of three commercial human whole-exome capture platforms.Asan, Xu Y, Jiang H, Tyler-Smith C, Xue Y, Jiang T, Wang J, Wu M, Liu X, Tian G, Wang J, Wang J, Yang H, Zhang X.Asan, et al.Genome Biol. 2011 Sep 28;12(9):R95. doi: 10.1186/gb-2011-12-9-r95.Genome Biol. 2011.PMID:21955857Free PMC article.
- Significance of molecular testing for congenital chloride diarrhea.Lechner S, Ruemmele FM, Zankl A, Lausch E, Huber WD, Mihatsch W, Phillips AD, Lewindon P, Querfeld U, Heinz-Erian P, Müller T, Janecke AR.Lechner S, et al.J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):48-54. doi: 10.1097/MPG.0b013e31820bc856.J Pediatr Gastroenterol Nutr. 2011.PMID:21694535
- Congenital chloride diarrhea in patient with SLC26A2 mutation - analysis of the clinical phenotype and differential diagnosis.Sun M, Tao N, Liu X, Yang Y, Su Y, Xu F.Sun M, et al.Pediatr Endocrinol Diabetes Metab. 2021;27(1):51-56. doi: 10.5114/pedm.2020.97465.Pediatr Endocrinol Diabetes Metab. 2021.PMID:33599438Free PMC article.Review.
- Exome and genome sequencing: a revolution for the discovery and diagnosis of monogenic disorders.Stranneheim H, Wedell A.Stranneheim H, et al.J Intern Med. 2016 Jan;279(1):3-15. doi: 10.1111/joim.12399. Epub 2015 Aug 7.J Intern Med. 2016.PMID:26250718Review.
Cited by
- Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity.Gill R, Cheung YH, Shen Y, Lanzano P, Mirza NM, Ten S, Maclaren NK, Motaghedi R, Han JC, Yanovski JA, Leibel RL, Chung WK.Gill R, et al.Obesity (Silver Spring). 2014 Feb;22(2):576-84. doi: 10.1002/oby.20492. Epub 2013 Oct 15.Obesity (Silver Spring). 2014.PMID:23616257Free PMC article.
- Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders.Fairfield H, Srivastava A, Ananda G, Liu R, Kircher M, Lakshminarayana A, Harris BS, Karst SY, Dionne LA, Kane CC, Curtain M, Berry ML, Ward-Bailey PF, Greenstein I, Byers C, Czechanski A, Sharp J, Palmer K, Gudis P, Martin W, Tadenev A, Bogdanik L, Pratt CH, Chang B, Schroeder DG, Cox GA, Cliften P, Milbrandt J, Murray S, Burgess R, Bergstrom DE, Donahue LR, Hamamy H, Masri A, Santoni FA, Makrythanasis P, Antonarakis SE, Shendure J, Reinholdt LG.Fairfield H, et al.Genome Res. 2015 Jul;25(7):948-57. doi: 10.1101/gr.186882.114. Epub 2015 Apr 27.Genome Res. 2015.PMID:25917818Free PMC article.
- Progress in Neoantigen Targeted Cancer Immunotherapies.Han XJ, Ma XL, Yang L, Wei YQ, Peng Y, Wei XW.Han XJ, et al.Front Cell Dev Biol. 2020 Jul 30;8:728. doi: 10.3389/fcell.2020.00728. eCollection 2020.Front Cell Dev Biol. 2020.PMID:32850843Free PMC article.Review.
- Approaches to homozygosity mapping and exome sequencing for the identification of novel types of CDG.Matthijs G, Rymen D, Millón MB, Souche E, Race V.Matthijs G, et al.Glycoconj J. 2013 Jan;30(1):67-76. doi: 10.1007/s10719-012-9445-7. Epub 2012 Sep 15.Glycoconj J. 2013.PMID:22983704Review.
- A single-center pilot study in Malaysia on the clinical utility of whole-exome sequencing for inborn errors of immunity.Ripen AM, Chear CT, Baharin MF, Nallusamy R, Chan KC, Kassim A, Choo CM, Wong KJ, Fong SM, Tan KK, Nachiappan JP, Teo KR, Chiow MY, Hishamshah M, Ghani H, Muralitharan RR, Mohamad SB.Ripen AM, et al.Clin Exp Immunol. 2021 Nov;206(2):119-128. doi: 10.1111/cei.13626. Epub 2021 Jul 13.Clin Exp Immunol. 2021.PMID:34060650Free PMC article.Clinical Trial.
References
- Cooper DN, Krawczak M, Antonorakis SE. The nature and mechanisms of human gene mutation. In: Scriver C, Beaudet al., Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 7th Ed. New York: McGraw-Hill; 1995. pp. 259–291.
- Hirschhorn JN. Genomewide association studies−illuminating biologic pathways. N Engl J Med. 2009;360:1699–1701. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases